Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Adverum Biotechnologies, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 92 | 2 | 77 | −13 |
| Shares | 63.2M | 142.1K | 58.2M | −4.87M (−7.7%) |
| Value | $82.4M | $186.0K | $70.0M | −$12.2M (−14.9%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 1,726,019 | $2.07M | 0.06% |
| Millennium Management LLC | 1,038,458 | $1.25M | 0.00% |
| Newtyn Management, LLC | 1,035,000 | $1.24M | 0.24% |
| Oasis Management Co Ltd. | 465,000 | $558.0K | 0.10% |
| Monaco Asset Management SAM | 447,004 | $536.0K | 0.25% |
| Ergoteles LLC | 419,800 | $504.0K | 0.02% |
| Worth Venture Partners, LLC | 248,800 | $425.0K | 0.26% |
| Susquehanna International Group, LLP | 94,890 | $113.0K | 0.00% |
| Qube Research & Technologies Ltd | 83,886 | $101.0K | 0.00% |
| XTX Topco Ltd | 37,770 | $45.0K | 0.02% |
| LMR Partners LLP | 30,987 | $37.0K | 0.00% |
| Balyasny Asset Management LLC | 23,617 | $28.0K | 0.00% |
| StoneX Group Inc. | 14,830 | $17.8K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 11,303 | $14.0K | 0.00% |
| Merit Financial Group, LLC | 10,000 | $12.0K | 0.00% |
| Brightworth | 10,000 | $12.0K | 0.00% |
Sold out (29)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (2)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 131,638 | $172.0K |
| Amalgamated Financial Corp. | 10,459 | $14.0K |